Ledger.Open graph →
SEC Form D · filed September 14, 2023

Olema Pharmaceuticals, Inc

Offering
$130.0M
Sold
$130.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

David C. Myles, Ph.D · San Francisco, CAExecSandra L. Horning, M.D · San Francisco, CADirectorSean Bohen, M.D., Ph.D · San Francisco, CAExec · DirectorAndrew C. Rappaport · San Francisco, CADirectorGraham L. Walmsley, M.D., Ph.D · San Francisco, CADirectorNaseem C. Zojwalla, M.D · San Francisco, CAExecYi C. Larson · San Francisco, CADirectorCyrus L. Harmon, Ph.D · San Francisco, CADirectorShane C. Kovacs · San Francisco, CAExecIan L. Clark · San Francisco, CADirectorGorjan L. Hrustanovic, Ph.D · San Francisco, CADirectorCynthia C. Butitta · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗